Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Eli Lilly and Company
With
This study consists of the following: * Screening period: 4 to 28-days * Part A: a 12-week blinded, placebo controlled treatment period * Part B: a 12-week blinded extension period * Part C: an optional 52-week open-label extension period * Part D: an additional optional 52-week open-label extension period * Follow up period: 28 days
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted